Treatments for macular degeneration: Summarising evidence using network meta-analysis

British Journal of Ophthalmology

Volumn 95, Issue 10, 2011, Pages 1476-1477

  Fadda, Valeria ^a   Maratea, Dario ^a   Trippoli, Sabrina ^a   Messori, Andrea ^a  

^a ESTAV   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; PLACEBO; RANIBIZUMAB; VASCULOTROPIN INHIBITOR; VERTEPORFIN;

COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG COST; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; LETTER; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; STATISTICAL ANALYSIS;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; MACULAR DEGENERATION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80053281377     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300316     Document Type: Letter

References (6)

1. Takeda AL, Colquitt J, Clegg AJ, et al. Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review. Br J Ophthalmol 2007;91:1177-82. (Pubitemid 47344893)
2. Tufail A, Patel PJ, Egan C, et al ABC Trial Investigators. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. BMJ 2010;340:c2459.
3. Caldwell DM, Ades AE, Higgins JPT. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 2005;331:897-900. (Pubitemid 41502718)
4. Bucher HC, Guyatt GH, Griffith LE, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997;50:683-91. (Pubitemid 27341818)
5. Fadda V, Maratea D, Trippoli S, et al. Network metaanalysis. Results can be summarised in a simple figure. BMJ 2011;342:d1555.
6. The CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. Publishe Online First: 2011. doi:10.1056/NEJMoa1102673.